Castle Biosciences Inc

NASDAQ: CSTL    
Share price (5/16/24): $24.22    
Market cap (5/16/24): $669 million
Search in Documents
Key Exhibits
External Links
1 Castle Biosciences Inc Expert Interviews, now on BamSEC.
 Powered by Tegus.

Material Contracts Filter

EX-10.6
from 10-Q 5 pages Name: Franklin Stokes Section 1. Eligibility
12/34/56
EX-10.5
from 10-Q 6 pages Name: Derek Maetzold Section 1. Eligibility
12/34/56
EX-10.4
from 10-Q 5 pages Name: Kristen Oelschlager Section 1. Eligibility
12/34/56
EX-10.3
from 10-Q 5 pages Name: Tobin Juvenal Section 1. Eligibility
12/34/56
EX-10.2
from 10-Q 8 pages Certain Confidential Information Contained in This Document, Marked by [***], Has Been Omitted Because It Is Both (I) Not Material and (II) Is the Type That the Registrant Treats as Private or Confidential. First Amendment to Lease Agreement
12/34/56
EX-10.38
from 10-K 9 pages Second Amendment to Commercial Contract - Unimproved Property
12/34/56
EX-10.20
from 10-K 36 pages Castle Biosciences, Inc. Severance and Change in Control Plan Effective Date: November 3, 2023
12/34/56
EX-10.3
from 10-Q 2 pages Recitals
12/34/56
EX-10.2
from 10-Q 6 pages Sixth Amendment to Standard Office Lease
12/34/56
EX-10.1
from 10-Q 32 pages Commercial Contract - Unimproved Property Use of This Form by Persons Who Are Not Members of the Texas Association of Realtors®, Inc. Is Not Authorized. ©texas Association of Realtors®, Inc. 2022
12/34/56
EX-10.4
from 10-Q 6 pages Fourth Amendment to Standard Office Lease
12/34/56
EX-10.32
from 10-K 2 pages Commercial Lease Amendment Use of This Form by Persons Who Are Not Members of the Texas Association of Realtors®, Inc. Is Not Authorized. ©texas Association of Realtors®, Inc. 2022
12/34/56
EX-10.29
from 10-K 2 pages Third Amendment to Standard Office Lease
12/34/56
EX-10.25
from 10-K 7 pages Fifth Amendment to Standard Office Lease
12/34/56
EX-10.16
from 10-K 5 pages Section 1. Introduction
12/34/56
EX-10.14
from 10-K 2 pages Castle Biosciences, Inc. Non-Employee Director Compensation Policy Adopted: June 8, 2019 Amended: January 28, 2021 Amended January 24, 2022 Amended: January 31, 2023
12/34/56
EX-10.13
from 10-K 23 pages Castle Biosciences, Inc. Stock Option Grant Notice
12/34/56
EX-10.12
from 10-K 9 pages Castle Biosciences, Inc. Restricted Stock Unit Grant Notice
12/34/56
EX-10.11
from 10-K 22 pages 1. General
12/34/56
EX-10.3
from 10-Q 53 pages Lease Agreement Between Aca Concourse East Unit 3 LLC and Castle Biosciences, Inc. Unit 3, Nova Place Concourse, Pittsburgh, Pennsylvania Contents
12/34/56